A volunteer named Ian Haydon buoyed the markets when he appeared on CNBC to say he felt fine after getting the vaccine. But he later revealed that after the second jab, he got chills and a fever of over 103Â degrees, lost consciousness, and "felt more sick than he ever has before." And those were just the short-term adverse effects. The long-term degenerative effects won't be known for years.
By May 22nd, Moderna's stock was down by 26% from its earlier high, making its 30% rise on a misleading press release look like a "pump and dump" scheme. On CNBC on May 19th, Jacob Frankel, a former Securities Exchange Commission lawyer, said Moderna's stock offering on the heels of hyped news was the type of action that would draw scrutiny by the SEC, and that it could have a criminal component.
Dual Use? Another Look at Moderna's mRNA Vaccine
Moderna's stock has more than tripled this year, taking it to a market cap of over $22 billion. STAT News called it "an astonishing feat for a company that currently sells zero products." Many of the companies actively developing COVID-19 vaccines have longer and more impressive track records. Why the keen interest in this "unicorn" startup that went public only in 2018 and has no record of market success?
Moderna's stock first shot up after the World Health Organization announced on February 24th that the world needed to prepare for a global pandemic, collapsing stock markets everywhere. In a well-timed press release the next day, Moderna announced that testing of its vaccine on humans would begin in March, rocketing its stock price up by nearly 30%. Mega-investors made tens of millions of dollars in a single day, including BlackRock, the world's largest asset manager, which made $68 million just on February 25th. BlackRock was called "the fourth branch of government" after it was tasked in March with dispensing up to $4.5 trillion in Federal Reserve credit through "special purpose vehicles" established by the Treasury and the Fed.
Moderna has other friends in high places, including the Pentagon. Several years ago, Moderna received millions of dollars from the Pentagon's Defense Advanced Research Projects Agency (DARPA), as well as from the Bill and Melinda Gates Foundation. Perhaps the fact that Moderna's mRNA vaccine is a "stealth virus" riding in on nanoparticles to evade the cell's defenses explains DARPA's interest in the technology. DARPA was behind the creation of both DNA and RNA vaccines, funding their early research and development by Moderna and by Inovio Pharmaceuticals Inc.
In a 2010 document titled "Biotechnology: Genetically Engineered Pathogens," the US Air Force acknowledged that it was studying "genetically engineered pathogens that could pose serious threats to society," including "binary biological weapons, designer genes, gene therapy as a weapon, stealth viruses, host-swapping diseases, and designer diseases." In December 2017, over 1,200 emails released under open records requests revealed that the US military is now the top funde r behind the controversial "genetic extinction" technology known as "gene drives." As investigative reporter Whitney Webb observed in a May 4th article, "these genetic 'kill switches' could also be inserted into actual humans through artificial chromosomes, which - just as they have the potential to extend life - also have the potential to cut it short."
Biowarfare is forbidden under international treaty, but the army's Medical Research Institute of Infectious Diseases at Fort Detrick says its investigations are to "protect the warfighter from biological threats" and to protect civilians from threats to public health. Even assuming that is true, are the army's technicians proficient enough to tinker with the genetic code without hitting a kill switch or two by mistake?
The military is thinking about war, the pharmaceutical companies and investors are thinking about profits, the politicians are thinking about getting a vaccine to market so the country can return to work, and even the regulators are bypassing proper safety tests in the rush to get the entire global population vaccinated. That means it's up to us, the recipients of these novel untested GMO vaccines, to demand some serious vetting before the military shows up at our doors with their prefilled RFID-chipped syringes some time later this year.
________________________
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).